Back
MoonLake Immunotherapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
MLTX
MoonLake Immunotherapeutics
Last Price:
$52.27
Seasonality Move:
32.39%
7 Day Trial
ALL ACCESS PASS
$
7
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.MoonLake Immunotherapeutics Stock Forecast
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 134.2% based on the past 4 years of stock performance.
-
MoonLake Immunotherapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is MoonLake Immunotherapeutics Stock Undervalued?The current MoonLake Immunotherapeutics [MLTX] share price is $52.17. The Score for MLTX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 134.2% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Sell
30
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics overpriced?
-
MoonLake Immunotherapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
64.98
52-Week Low:
37.55
Prediction Charts
Market Cap:
3.3B
Price in USD:
52.17
Volume:
192.8K
Beta:
1.32
Technical Analysis
SMA50:
50.78
SMA100:
49.66
SMA200:
46.72
52-Wk Change:
-9.32%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?Yes, MoonLake Immunotherapeutics is a publicly traded company.
-
What is the MoonLake Immunotherapeutics stock quote today?The MoonLake Immunotherapeutics stock price is 52.17 USD today.
-
How to buy MoonLake Immunotherapeutics stock online?You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 55.13 | 51.30 | 56.00 | 51.03 |
| Dec-4 | 51.40 | 53.06 | 54.54 | 51.05 |
| Dec-5 | 53.31 | 53.50 | 54.00 | 52.24 |
| Dec-6 | 53.75 | 54.31 | 55.04 | 53.75 |
| Dec-9 | 54.52 | 52.75 | 54.52 | 52.50 |
| Dec-10 | 52.43 | 53.85 | 53.98 | 51.55 |
| Dec-11 | 54.09 | 53.54 | 54.50 | 53.00 |
| Dec-12 | 53.31 | 53.77 | 54.46 | 52.94 |
| Dec-13 | 53.87 | 51.34 | 54.03 | 50.60 |
| Dec-16 | 51.00 | 52.98 | 53.09 | 51.00 |
| Dec-17 | 53.12 | 56.30 | 58.26 | 52.88 |
| Dec-18 | 56.32 | 52.25 | 56.87 | 51.56 |
| Dec-19 | 52.33 | 51.88 | 53.25 | 50.40 |
| Dec-20 | 51.71 | 52.17 | 54.10 | 50.21 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.77 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.